BCM
PDLI

BTC Capital Management’s PDL BioPharma, Inc. PDLI Stock Holding History

BTC Capital Management’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-96,218
Closed -$225K – 188
2018
Q2 		$225K Buy
96,218
+3,664
+4% +$10.2K 0.05% 139
2018
Q1 		$272K Buy
92,554
+954
+1% +$2.6K 0.04% 164
2017
Q4 		$252K Buy
+91,600
New +$281K 0.04% 153

Other funds holding PDLI

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Kennedy Capital Management
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Brandes Investment Partners
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

BTC Capital Management's PDLI Position: Q3 2018 in Review

BTC Capital Management sold out of PDL BioPharma, Inc. (PDLI) in Q3 2018, closing a stake of 96,218 shares — an estimated $225K sold.

BTC Capital Management first reported a position in PDLI in Q4 2017 and held it in 3 quarters. The position peaked at $272K in Q1 2018. 152 funds tracked by Wall St. Rank hold PDLI as of Q3 2018.

  • BTC Capital Management reported no remaining PDL BioPharma, Inc. position as of Q3 2018 after selling out during the quarter.
  • BTC Capital Management sold 96,218 PDL BioPharma, Inc. shares in Q3 2018, an estimated $225K.
  • BTC Capital Management first reported a position in PDL BioPharma, Inc. in Q4 2017 and held it in 3 quarters.
  • BTC Capital Management's PDL BioPharma, Inc. position peaked at $272K in Q1 2018.
  • 152 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2018.

Based on BTC Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.